On Friday, Sabra Healthcare REIT got a positive adjustment to its Relative Strength (RS) Rating, from 79 to 82.
Hone Your Stock-Picking Skills By Focusing On These Factors
This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks holds up against all the other stocks in our database.
History reveals that the best stocks often have an RS Rating north of 80 in the early stages of their moves.
Sabra Healthcare REIT is not currently offering a proper buying opportunity. See if the stock goes on to build a sound pattern that could launch a new move.
Sabra Healthcare REIT reported 3% EPS growth in its most recent report. Sales increased 7%.
The company holds the No. 6 rank among its peers in the Finance-Property REITs industry group. CareTrust REIT, Postal Realty Trust Cl A and NetSTREIT are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength